Transitioning individuals with peanut allergy from US Food and Drug Administration-approved peanut oral immunotherapy to a dietary peanut product
- PMID: 36210007
- DOI: 10.1016/j.anai.2022.09.037
Transitioning individuals with peanut allergy from US Food and Drug Administration-approved peanut oral immunotherapy to a dietary peanut product
MeSH terms
Substances
LinkOut - more resources
Full Text Sources